Walleye Capital’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Walleye Capital’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Hold	169,502	–	–	﹤0.01%	3632
2026 Q1	$127K	Hold	169,502	–	–	﹤0.01%	3569
2025 Q4	$120K	Sell	169,502 -300	-0.2%	-$250	﹤0.01%	3797
2025 Q3	$127K	Hold	169,802	–	–	﹤0.01%	3585
2025 Q2	$149K	Buy	169,802 +64	+0%	+$49	﹤0.01%	3566
2025 Q1	$127K	Buy	169,738 +54,122	+47%	+$41.1K	﹤0.01%	3518
2024 Q4	$102K	Buy	+115,616	New	+$75.6K	﹤0.01%	4134

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Walleye Capital's OACCW Position: Q2 2026 in Review

Walleye Capital held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q2 2026 at 169,502 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #3632.

Walleye Capital first reported a position in OACCW in Q4 2024 and has held it in 7 quarters since. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

Walleye Capital held 169,502 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $160K as of Q2 2026.
Walleye Capital left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3632 holding.
Walleye Capital first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 7 quarters since.
27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.